INO vs TJX · $88.0M cap vs P/E 32, rev $29.50B
Inovio Pharmaceuticals Inc (INO) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
INO currently screens at market cap $88.0M. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the INO and TJX stock pages for the full models.
Not investment advice.